Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Ig ; 35(6): 707-714, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37476887

RESUMO

Abstract: The Erice 58 Charter titled "The Health of Migrants: a Challenge of Equity for the Public Health System", was unanimously approved at the conclusion of the 58th Residential Course of the School of Epidemiology and Preventive Medicine 'Giuseppe D'Alessandro' entitled "The Health of Migrants: a Challenge of Equity for the Public Health System. Epidemiological, clinical-relational, regulatory, organisational, training and public communication aspects at international, national and local level', which took place from 28 March to 2 April 2022 in Erice (Sicily, Italy), at the 'Ettore Majorana' Foundation and Centre for Scientific Culture. The Course was promoted by the Italian Society of Migration Medicine (S.I.M.M.) and the Italian Society of Hygiene, Preventive Medicine and Public Health (SItI), with the collaboration and patronage of the Istituto Superiore di Sanità (ISS). 72 learners participated (mainly resident doctors in 'Hygiene and Preventive Medicine' but also other health service professionals), whose average age was 37 years; on the basis of territorial origin, 13 of the 20 Italian regions were represented. During the intense learning experience, which consisted of 18 frontal lessons (with 20 lecturers from the bio-medical, socio-anthropological and journalistic fields) and 7 working group sessions (supported by 4 classroom tutors in addition to the lecturers) in 'blended learning' mode, the various dimensions and critical issues related to the possibility of guaranteeing truly inclusive health policies for foreigners/migrants, throughout the country, were identified and discussed from an 'Health Equity' perspective. This enabled a small editorial group to draw up the basic document that, in the last session of the Course, was discussed and modified by all participants into the version of the 'Erice 58 Charter' presented here.


Assuntos
Saúde Pública , Migrantes , Humanos , Adulto , Saúde Pública/educação , Higiene , Itália , Sicília , Instituições Acadêmicas
2.
Ann Ig ; 30(5): 431-435, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30062371

RESUMO

INTRODUCTION: The internationally adopted child is a fragile subject who often shows an incomplete health documentation, which hinders the complete assessment of health status. MATERIALS AND METHODS: Between January 2010 and June 2016, at the University Hospital "AOUP P. Giaccone" of Palermo, we reviewed the health documentations of 111 children recently arrived in Italy following the conclusion of the international adoption procedure. 62.2% of the children were male, of various nationalities and with an average age of 7 years (± 3.4). This study aims to detect, in the observed sample, the reliability of the vaccinal documentation and the real acquired immunization. We intend to estimate the presence of IgG against Measles, Mumps, Rubella and Hepatitis B viruses. RESULTS: Percentages of subjects with a complete correspondence between documentation attesting the successful vaccination and the effective immunization were: 78% for measles, 66% for mumps, 84% for rubella, 71% for hepatitis B. Percentages of subjects without vaccinal documentation but with positive evidence of IgG were: 50% for measles, 38% for mumps, 71% for rubella, 50% for hepatitis B. CONCLUSIONS: The partial correspondence found between vaccinations performed and real immune status can be attributed to several reasons: poor reliability of the received health documentation, the complex economic situation of the health services in the countries of origin, the incorrect vaccines storage or the administration beyond the expiration date, the poor immunological response due to concomitant diseases or severe malnutrition, the probable non-administration of the expected booster dose. Particular attention needs to be paid to this population, which may represent a risk group susceptible to vaccine-preventable diseases.


Assuntos
Criança Adotada/estatística & dados numéricos , Imunoglobulina G/imunologia , Vacinação/estatística & dados numéricos , Vacinas/administração & dosagem , Criança , Pré-Escolar , Documentação/normas , Emigração e Imigração , Feminino , Hepatite B/imunologia , Hepatite B/prevenção & controle , Hospitais Universitários , Humanos , Imunização Secundária/estatística & dados numéricos , Lactente , Masculino , Sarampo/imunologia , Sarampo/prevenção & controle , Caxumba/imunologia , Caxumba/prevenção & controle , Reprodutibilidade dos Testes , Rubéola (Sarampo Alemão)/imunologia , Rubéola (Sarampo Alemão)/prevenção & controle , Sicília , Vacinas/imunologia
3.
Nutr Metab Cardiovasc Dis ; 23(7): 642-9, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22502765

RESUMO

INTRODUCTION: No information exists, to our knowledge, about the possible role of cardiovascular drug administration in the acute phase of ischemic stroke and possible effects on stroke outcome. The aim of our study was to evaluate the relationship between in-hospital treatment with cardiovascular drugs in patients with acute ischemic stroke and some outcome indicators. METHODS AND RESULTS: 1096 subjects enrolled in the GIFA study, who had a main discharge diagnosis of ischemic stroke represent the final sample. Drugs considered for the analysis were the following: ACE-inhibitors (ACEI), angiotensin II receptor blockers (ARBs), statins, calcium-channel-blockers (CCBs), antiplatelet (APL) drugs, antivitamin-k (VKAs), and heparins. As outcome indicators we choose in-hospital mortality, cognitive function evaluated by Hodkinson Abbreviated Mental Test (HAMT), and functional status evaluated by activity daily living (ADL). Indicators of a good outcome were: no in-hospital mortality, HAMT >6 and 0 ADL impaired. Patients with a good outcome showed a higher rate of in-hospital treatment with ACE-inhibitors, calcium-channel blockers and a lower rate of pre-treatment with heparin. CONCLUSIONS: Our study suggests that if a patient with acute ischemic stroke has higher SBP at admission, higher total cholesterol plasma levels, a lower Charlson index and is treated with ACE-inhibitors, calcium channel blockers and antiplatelet drugs, the short term outcome is better in terms of in-hospital mortality and functional indicators such as cognitive and functional performance at discharge.


Assuntos
Isquemia Encefálica/tratamento farmacológico , Fármacos Cardiovasculares/uso terapêutico , Acidente Vascular Cerebral/tratamento farmacológico , Atividades Cotidianas , Idoso , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Isquemia Encefálica/diagnóstico , Isquemia Encefálica/epidemiologia , Isquemia Encefálica/fisiopatologia , Bloqueadores dos Canais de Cálcio/uso terapêutico , Fármacos Cardiovasculares/efeitos adversos , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/prevenção & controle , Comorbidade , Feminino , Avaliação Geriátrica , Humanos , Hipercolesterolemia/epidemiologia , Hipertensão/epidemiologia , Itália/epidemiologia , Masculino , Inibidores da Agregação Plaquetária/uso terapêutico , Prognóstico , Estudos Retrospectivos , Acidente Vascular Cerebral/diagnóstico , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/fisiopatologia , Fatores de Tempo
4.
Int J Immunopathol Pharmacol ; 21(1): 247-50, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18336754

RESUMO

Heparin-Induced Thrombocytopenia (HIT) is a serious and potentially fatal complication of patients on heparins. Its management is difficult and it can be more complicated in patients with cancer because of the hemorrhagic risk carried out by direct inhibitor of thrombin, the currently approved drug for HIT. At present, it is not clear whether cancer patients also have an increased risk of HIT. We describe the case of a patient with occult cancer at the moment of the index venous thrombosis, who developed Deep Vein Thrombosis (DVT) and concomitant HIT with thrombotic complications (recurrent contra-lateral venous thrombosis). The management of HIT was efficaciously based on the combined use of alternative antithrombotic regimens (Dermatan-Sulphate and Defibrotide), without an increased risk of bleeding. This case highlights the potential relationship between DVT, as first episode of an occult cancer, and the risk of developing HIT. The use of alternative antithrombotic therapy seems to be efficacious even in this high-risk cancer patient.


Assuntos
Neoplasias da Vesícula Biliar/complicações , Heparina/efeitos adversos , Trombocitopenia/complicações , Tromboembolia Venosa/etiologia , Idoso , Feminino , Humanos , Recidiva , Trombocitopenia/induzido quimicamente
5.
Int Angiol ; 26(3): 266-9, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17622210

RESUMO

AIM: The diabetic foot syndrome is the most frequent cause of hospitalization of diabetic patients and one of the economically most demanding complications of diabetes. People with diabetes have been shown to have higher mortality than people without diabetes, but the cerebrovascular risk profile of these patients is not fully evaluated. The aim of our study was to evaluate the possible role of diabetic foot as a cerebrovascular risk marker in type 2 diabetic patients. METHODS: We enrolled 102 type 2 diabetes patients with diabetic foot and 123 diabetic patients without diabetic foot. RESULTS: Statistically significant differences were found in the distribution of the main cardiovascular risk factors with exception of hypertension. We observed a higher prevalence of previous cerebrovascular events (transient ischemic attack, ischemic stroke) and of incidence of new onset cerebrovascular events at a 5-year follow-up. Regarding clinical subtype of ischemic stroke classified according to Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification on a retrospective and prospective basis, we observed a higher prevalence of both the lacunar and large artery atherosclerosis subtype with a slight higher prevalence of lacunar subtype in patients with diabetic foot. CONCLUSION: Our results show a worse cerebrovascular risk profile in diabetic patients with diabetic foot than in diabetic subjects without foot ulceration with a higher prevalence of cardiovascular risk factors and of anamnestic cerebrovascular events and incidence of new cerebrovascular events at a 5-year follow-up.


Assuntos
Isquemia Encefálica/etiologia , Pé Diabético/complicações , Idoso , Isquemia Encefálica/epidemiologia , Diabetes Mellitus Tipo 2/complicações , Feminino , Seguimentos , Humanos , Itália/epidemiologia , Masculino , Prevalência , Estudos Retrospectivos , Fatores de Risco
6.
G Ital Cardiol ; 29(12): 1478-87, 1999 Dec.
Artigo em Italiano | MEDLINE | ID: mdl-10687111

RESUMO

We evaluated the pre- and postnatal outcome of isolated atrioventricular (AV) block detected during fetal life in order to identify factors that may affect the natural history of this lesion and to assess prenatal therapy. Over the past eight years, we consecutively evaluated 10 fetuses with complete AV block. The mean gestational age at diagnosis was 25.3 weeks and the mean heart rate was 57 bpm; two fetuses were hydropic. During pregnancy, one fetus suddenly died, while 6 out of 9 fetuses had a mean reduction in heart rate of 17.8 bpm; 4 patients had heart rate < 50 bpm. Five fetuses developed heart failure, which was severe in 2 cases and mild in 3. The mean gestational age at delivery was 31 weeks. Dexamethasone was administered to the mothers during pregnancy in 4 cases without modification of AV block and/or of heart rate, but in 3 out of 4 fetuses the general condition remained stable in spite of the reduction in heart rate in two of them. Sympathomimetic drugs were employed in 3 cases with an increase in fetal heart rate, but maternal discomfort appeared in two cases. Three newborns died during the first week of life, two of hydrops and one of persistent pulmonary hypertension. Cardiac pacing was performed in 6/9 patients within the first 8 months of life and in 3 within the first 2 days. In conclusion, morbidity and mortality are high when AV block is detected during fetal life. Negative prognostic factors are hydrops and a heart rate < 50 bpm. Pre-term delivery to enable cardiac pacing is probably the therapy of choice if gestational age is > 27-28 weeks. Sympathomimetic drugs are effective but are poorly tolerated by the mothers. Dexamethasone has no effect on AV block and/or heart rate, but may improve clinical tolerance of conduction disturbance.


Assuntos
Doenças Fetais/diagnóstico por imagem , Doenças Fetais/tratamento farmacológico , Bloqueio Cardíaco/congênito , Bloqueio Cardíaco/tratamento farmacológico , Adulto , Feminino , Bloqueio Cardíaco/diagnóstico por imagem , Humanos , Recém-Nascido , Gravidez , Ultrassonografia Pré-Natal
8.
Science ; 205(4404): 401-2, 1979 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-17790852

RESUMO

Soft x-ray contact microscopy, utilizing single-shot exposures of approximately 60 nanoseconds duration in polymethyl methacrylate, has been realized with a resolution of 300 angstroms. The radiation spectrum is intense in the "window" between 23 and 44 angstroms where water is transparent compared to biological materials, and therefore permits viewing of wet samples.

9.
Science ; 200(4341): 531-3, 1978 May 05.
Artigo em Inglês | MEDLINE | ID: mdl-644311

RESUMO

The crystal and molecular structure of the widely used buffer tris(hydroxymethyl)aminomethane (tris) has been determined from single-crystal diffractometer data to a standard agreement factor (R value) of 0.026 and bond length standard deviations of 0.002 angstrom. Tris crystallizes in the orthorhombic system, space group Pn21a, with four molecules per unit cell; a = 8.844(1) angstroms, b = 7.794(1) angstroms, and c = 8.795(1) angstroms. The center-to-center distances of tris molecules in the ordered phase range from 0.4 to 1.0 angstrom less than they do in the orientationally disordered (plastic) phase of similar molecules.


Assuntos
Trometamina , Acetilcolina/antagonistas & inibidores , Cristalografia , Ligação de Hidrogênio , Conformação Molecular , Trometamina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...